MARSHALL WACE, LLP

Position in TARA — Protara Therapeutics, Inc.

CIK 1318757 LONDON, X0

Position in TARA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,677,899

+$2,413,591 QoQ

Shares Held

701,021

+1281.8% QoQ

Ownership

1.19%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#20

of 118 holders

Holding Since

Mar 2021

10 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. TARA ranks #128 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	543,897	$270,169,956
2	INCY	Incyte Corp	1,310,154	$148,519,056
3	RPRX	Royalty Pharma plc	2,450,669	$137,409,009
4	SYRE	Spyre Therapeutics, Inc.	991,693	$88,042,503
5	ALNY	Alnylam Pharmaceuticals, Inc.	259,799	$78,207,292
6	TVTX	Travere Therapeutics, Inc.	1,333,207	$75,739,488
7	MANE	Veradermics, Inc	585,560	$71,988,746
8	DFTX	Definium Therapeutics, Inc.	1,298,946	$61,102,419

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,677,899	701,021	+1281.8%	Shares	Other	2026-08-13
2026-03-31	$264,308	50,731	-91.3%	Shares	Other	2026-05-15
2025-12-31	$3,115,533	584,528	+104.7%	Shares	Other	2026-02-13
2025-09-30	$1,242,298	285,586	-21.2%	Shares	Other	2025-11-13
2025-06-30	$1,098,452	362,526	+368.7%	Shares	Other	2025-08-13
2024-09-30	$141,552	77,351	0.0%	Shares	Other	2024-11-14
2024-06-30	$160,890	77,351	+409.2%	Shares	Other	2024-08-14
2021-09-30	$105,114	15,190	-13.0%	Shares	Sole	2021-11-15
2021-06-30	$170,148	17,469	-58.5%	Shares	Sole	2021-08-13
2021-03-31	$663,220	42,136	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.